trending Market Intelligence /marketintelligence/en/news-insights/trending/gvgm2s_pqn0ynzqf6xut4a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Former GSK exec joins Aclaris Therapeutics as chief medical officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Former GSK exec joins Aclaris Therapeutics as chief medical officer

Aclaris Therapeutics Inc. appointed David Gordon chief medical officer.

Gordon recently served as senior vice president and head of dermatology research at GlaxoSmithKline PLC.

Wayne, Pa.-based Aclaris Therapeutics develops therapies in the areas of medical and aesthetic dermatology as well as immunology.